Legislation & Regulation

AMCP members gathered in Washington, DC, on May 18–20 for Legislative Days 2026, to advocate for managed care's legislative priorities addressing patient access, affordability, and care delivery.

The bipartisan Main Street Pharmacy Access Act (H.R. 3164/S. 2426), which would allow Medicare to reimburse pharmacists for testing and treating certain respiratory illnesses in states that already authorize those services, cleared the House Committee on Ways and Means on May 21, 2026.

Press release announcing that The Main Street Pharmacy Access Act has advanced in the Ways and Means Committee. AMCP thanks committee members for their leadership and recognizes the role AMCP members played in advocating directly with lawmakers to help move this issue forward. This legislation is an important step toward improving access to pharmacist-provided care for Medicare patients — in states that already authorize pharmacists to perform these services.